The competitive exclusion (CE) action of Aviguard (AG) and its effects on the antibody response of chicks were evaluated in this study. We observed that AG protected the chicks from overwhelming colonization. Fourteen days after infection, fewer AG-pretreated than nonpretreated chicks shed salmonellae from their coloaca in both infected groups, although much less from SE-infected chicks. Antibody titers of sera produced to Salmonella typhimurium (ST) and SE in pretreated and non-pretreated chicks were not significantly different. Immunoblotting showed that these antibodies reacted with SDS-PAGE-separated 71.4, 67.7, 44.0, and 30.3 kDa proteins detectable in the test strains. Few weak bands of doubtful significance were observed in the cross-reaction between the sera of ST- and SE-infected chicks with ST and SE antigens, respectively. Our study showed that AG protected chicks from overwhelming colonization by salmonellae, and neither altered the antigenic proteins of infecting salmonellae nor their recognition by specific antibodies produced in response to the infection.

Chlamydia trachomatis (CT) infections are among the sexually transmitted diseases known to increase the risk for human immunodeficiency virus infection. Serum samples from 34 consenting AIDS patients which attended the Government-approved Antiretroviral Treatment (ART) Facility at the National Institute for Pharmaceutical Research and Development (NIPRD), Abuja between April 2005 and March 2006 were screened by enzyme immunoassay (EIA) for the presence of anti-CT antibodies using ImmunoComb ® Chlamydia Bivalent IgG Test kit (Orgenics, Israel). Anti-CT antibodies were detected in ten (29.4%) of the thirty-four patients tested. The detection rate was higher among the females (33.3%) than the males (23.1%). Patients of the age group 31-45 years had the highest detection of anti-C. trachomatis antibodies, followed by those of age group 16-30 years. The result of the present study suggests the presence of anti-CT antibodies in AIDS patients, and reinforces the need for routine screening for anti-CT antibodies as a necessary intervention to reduce the burden of chlamydial diseases and to reduce the risk of HIV and its spread in Nigeria. The outcome of this study also provides justification for the possible inclusion of anti-chlamydial agents in the National AIDS Management Plan to treat associated C. trachomatis infections.